69 results
424B5
PRAX
Praxis Precision Medicines Inc
29 Mar 24
Prospectus supplement for primary offering
4:29pm
residents of the United States;
persons holding our common stock or pre-funded warrants as part of a hedge, straddle or other risk reduction strategy
424B5
PRAX
Praxis Precision Medicines Inc
27 Mar 24
Prospectus supplement for primary offering
4:49pm
or pre-funded warrants as part of a hedge, straddle or other risk reduction strategy, or as part of a conversion transaction or other integrated
8-K
EX-99.2
PRAX
Praxis Precision Medicines Inc
5 Mar 24
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
7:13am
or changes strategy to complete task. 3 = Severely abnormal. Cannot drink from a glass or uses straw or sippy cup. 11 items from the well-established … strategy Essential1 Phase 2b set foundation for the Essential3 Phase 3 program Sets up a clear path to registration Strong efficacy signal with robust
424B5
1xs85yxgip7jyb
12 Jan 24
Prospectus supplement for primary offering
5:20pm
424B5
j332fg
10 Jan 24
Prospectus supplement for primary offering
5:28pm
PRE 14A
waeix1s0csaiewx3h5
4 Oct 23
Preliminary proxy
7:56am
8-K
EX-99.2
2f7kz47c
9 Aug 23
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2023 Financial Results
8:27am
424B5
rrchi l7v4
20 Jun 23
Prospectus supplement for primary offering
6:02am
424B5
jcednv3ik 2nd
15 Jun 23
Prospectus supplement for primary offering
5:26pm
8-K
EX-99.1
a21qjtm
28 Nov 22
Regulation FD Disclosure
8:04am
8-K
EX-99.1
4c2orp ptlntzwi1r6
9 Nov 22
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4:03pm
8-K
EX-99.2
b34c cajn0v
9 Nov 22
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4:03pm